Weight Loss Associated with Reboxetine Use in Adolescents

Abstract

Get full access to this article

View all access options for this article.

References

Cortese

, Moreira-Maia

, St Fleur

, Morcillo-Penalver

, Rohde

, Faraone

: Association between ADHD and obesity: A systematic review and meta-analysis. Am J Psychiatry, 2015 [Epub ahead of print].

Halford

, Cooper

, Dovey

: The pharmacology of human appetite expression. Curr Drug Targets, 5:221–240, 2004.

Poyurovsky

, Fuchs

, Pashinian

, Levi

, Faragian

, Maayan

, Gil-Ad

: Attenuating effect of reboxetine on appetite and weight gain in olanzapine-treated schizophrenia patients: A double-blind placebo-controlled study. Psychopharmacology, 192:441–448, 2007.

Riahi

, Tashakori

, Izadi-Mazidi

, Salehi-Veysi

: Effectiveness of reboxetine in treatment of outpatient children and adolescents with attention deficit-hyperactivity disorder with comorbid anxiety disorders. Iran J Psychiatry, 8:195–200, 2013.

Schatzberg

: Clinical efficacy of reboxetine in major depression. J Clin Psychiatry, 61:31–38, 2000.

Silveira

, Zanatto

, Appolinario

, Kapczinski

: An open trial of reboxetine in obese patients with binge eating disorder. Eat Weight Disord, 10:93–96, 2005.

Toren

, Ratner

, Weizman

, Lask

, Ben-Amitay

, Laor

: Reboxetine maintenance treatment in children with attention-deficit/hyperactivity disorder: A long-term follow-up study. J Child Adolesc Psychopharmacol, 17:803–812, 2007.

Choi

Y-J

: Efficacy of adjunctive treatments added to olanzapine or clozapine for weight control in patients with schizophrenia: A systematic review and meta-analysis. ScientificWorldJournal, 2015 [Epub ahead of print].